http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-298345-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1814fde10db6ee69cee1f1a2bd4bd71 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 1996-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9aa7c1aafce55d3c9c287c15a98d06b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31211d8ea5a5a8c6ae080acb918cac8b |
| publicationDate | 2007-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-298345-B6 |
| titleOfInvention | Pharmaceutical dipeptide agents with angiostatic action and methods for their use |
| abstract | The use of a dipeptide R'-Glu-Trp-R '', an analogue thereof, or a derivative thereof, or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical composition for inhibiting neovascularization in a subject, wherein R 'and R' 'are absent or represent an independently selected amide-containing moiety an imide, ester, anhydride, ether, methyl-alkyl ester or ethyl-alkyl ester, alkyl, aryl, wherein R 'is also an amide bond between the amine and said Glu and the side chain carboxylate of said GLU, wherein the molecular weight of the dipeptide is less than 5000 Dalton, and neovascularization is a pathological condition selected from neovascularization of tumor, angioma, neovascularization after stroke treatment, neovascularization caused by head injury, restenosis after angioplasty, neovascularization related to liver disease, substance-induced neovascularization induced by substance, angiogenic dysfunction related to excess hormone, neovascular consequences of diabetes , neovascular consequences of high pressure or neovascularization caused by sheath injury or cold injury. |
| priorityDate | 1995-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.